Dr. John Mitchell: IPC’s Ongoing Efforts Related to COVID-19

Mitchell: I’m an optimist. I have to just say that upfront. My view of things tends not to be as doom and gloom as maybe some others might be. I’m actually seeing some rays of sunshine starting to sneak through the slats of people shuttering their doors—little positive signs where people are saying, “This is starting to happen,” or, “We’re looking to do this or we’re re-engaging in this fashion,” that I see as positive indicators that, in some states, people are claiming the curve has flattened. The cases are dropping, and the rate is slowing—that sort of thing. I’m encouraged that there could be a shift to come back. But even when that happens, there’s going to be a little bit of drag on the system. It’s not like everybody turns around and goes, “Great, everything’s normal next week. Let’s go back to the way we were operating.” As you mentioned, the supply chains have to make sure that all those products are available, and then demand has to pick up.

There’s been a big scare across the globe, especially as you think about consumer products. People have to get comfortable with, “I can act normally again,” as opposed to, “I’m just trying to worry about whether I can buy toilet paper.” Some of those attitudes have to change for things to flow back. But I am confident that we are responding well. There are still areas that we need to improve. I use the example of ventilators. There’s still a demand for those, and there is a challenge in trying to find qualified manufacturers that can build the parts for it in the proper way. It’s not like you can go down to any board shop and say, “Build this for us.” You’d need to be doing it in the proper way because you don’t want to have that ventilator break down on you.

There are still challenges, but we are hopefully moving more toward handling those challenges and then soon thereafter, trying to move things back to a little bit more normalcy. The challenges will be in, first—as the industry pointed out—how quickly will the demand return will be the big question. Once you have the demand, getting the right parts going forward will be a concern.

Matties: We’ve mentioned it several times, but ventilators and medical products are strong drivers in our industry right now. And those orders will start to subside as the curve flattens and the need for ventilators diminishes. What sort of forecast does IPC have for once that happens?

Mitchell: We don’t have a specific forecast for that. That’s a great question. Maybe it’s something that I can ask in our upcoming meeting in terms of how you will respond if you’re not building ventilators. Not everybody is building ventilators, though. Let me maybe respond to it in that fashion. There are only certain organizations that have the credentials to work on these products. As far as I’m aware, no one has come out and said, “We’re willing to release our quality standards on ventilators so that anybody can build them,” because that’s not going to help anyway. If your life depends on a ventilator, and suddenly it fails because it didn’t go through the right reviews and quality regulations, then that’s a problem. Only certain organizations can do that, but there are a lot of shifts that are going on in the marketplace. If that changes in two weeks or a month and we suddenly have enough, a million ventilators will have been created, and supply will be at parity.

At that stage, there will be a little bit more calming in the market, and people will start shippingf their normal goods. With the workforce shortage will, I don’t expect things to go back to 100% right away. I just shared an update on the China piece on LinkedIn. Today, China is somewhere between 85% and 98%. In February, they were trying to get to 50%, and in March, they were flirting with the goal of 80%–85%. Now, we are mid-April, and they’re still not 100%, so it’s going to take some time to ramp up for all those same reasons. People don’t want to have a relapse of the virus, so there’s still limited transportation and changing how you work, but it will come back.

Matties: Regarding ventilators, it’s not just the actual bare board fabricators, but it’s the base materials and components. It’s a strong driver throughout the entire supply chain for us right now. It will be interesting to see what your committees or teams come up with to that forecast or what impact they feel it will have. I know you’re an optimist, but what sort of concerns do you have for the industry right now?

Mitchell: One of my concerns is that right now, people need to pay more attention to the real numbers as opposed to the fear. It is a disease or a virus or a pandemic that can impact you. But when we look at the actual numbers, the U.S. has become the most infected country in terms of cases. But what are the real risk factors, and how are we mitigating those? We’ve seen several different, more famous people in the news saying, “So and so has contracted it.” I haven’t seen any case where those people have died from it. We’re figuring out how to manage it. If we can manage that fear, then we can come back. But if we can’t manage that fear, it’s just going to slow things down. And my concern, frankly, is fear sells in the larger news pieces. If we can’t start reporting on here’s how to be safe, such as success stories and survival cases, then we’re just going to propagate that fear even further, longer.

Matties: Do you have any closing thoughts or stories of humanity, if you will, that you want to share?

Mitchell: At some point, this is going to touch all of us personally. I have a nephew and a cousin who contracted it, and they’ve weathered the storm. I joked with them and said, “We need to get your little antibody badge so that you can walk around and everybody can say, ‘That person is safe.’” Please don’t take my advice as being from a medical professional at all. We’re all going to be impacted in some way by this, I imagine. We need to recognize that. In our case, fortunately, no one has been fatal in our organization. I am impressed by and proud of this industry. We are stepping up and helping be part of the solution. People aren’t quibbling about, “This is my business or that business,” at all. The industry is sharing best practices with each other in trying to help each other.

Now, this is not an unusual thing. This has been going on, but in this time of crisis, we’ve seen it highlighted even more in how the heads of these organizations that build the electronics, save lives, make our day to day better and are working together to try to make sure that everyone as an industry is successful so that, in turn, the world can get back to being a safer, happier place.

Matties: Those are great thoughts, John. Again, thank you very much for taking the time to help keep our industry well-informed.

Mitchell: My pleasure.

Matties: Once again, you’ve been listening to John Mitchell, president and CEO of IPC.


Suggested Items

I-Connect007 Editor’s Choice: Five Must-Reads for the Week

08/12/2022 | Andy Shaughnessy, I-Connect007
There was some good news this week, as Republicans and Democrats managed to cooperate long enough to pass the CHIPS Act. Members of the House and Senate don’t usually act until they get worried about being voted out of office, so pardon me if I’m not ready to sing “Happy Days Are Here Again” just yet. But this is still really good news; the politicians are on the record now, and we can hold them accountable.

Challenges of the 2022 PCB Market: The Party’s Over

08/08/2022 | Pete Starkey, I-Connect007
With his knowledgeable insight into the business and technology of the printed circuit industry, Dr. Shiuh-Kao Chiang, managing partner at Prismark Partners, has put a global perspective on the challenges of the 2022 PCB market. His presentation at the EIPC Summer Conference in Orebro, Sweden, on June 14 was eagerly awaited by an attentive audience, keen to share his vision. From his comments, it was clear that 2022 will be an interesting year and does not appear particularly friendly for the PCB business.

I-Connect007 Editor’s Choice: Five Must-Reads for the Week

08/05/2022 | Nolan Johnson, I-Connect007
The Top 5 list this week contains industry analysis from IPC’s Shawn DuBravac, news on the passage of the U.S. “CHIPS Plus” bill, new materials from Ventec, news about a fab for sale, and a chemistry company completing their acquisition, plus a brand new book in the I-Connect007 eBooks series.

Copyright © 2022 I-Connect007. All rights reserved.